| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $74.0M | +124.8% |
| Cost of Revenue | $194.7M | +61.4% |
| R&D Expense | $93.5M | +35.8% |
| SG&A Expense | $131.2M | +77.4% |
| Operating Income | -$345.4M | -49.9% |
| Interest Expense | $6.0M | -77.8% |
| Pre-tax Income | -$343.4M | -37.5% |
| Income Tax | -$392K | -1080.0% |
| Net Income | -$343.0M | -141.9% |
| EPS (Basic) | -$1.97 | +98.7% |
| EPS (Diluted) | -$1.97 | +98.7% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $281.1M | — |
| Accounts Receivable | $30.6M | +149.8% |
| Inventory | $10.3M | +58.4% |
| Current Assets | $343.5M | — |
| Total Assets | $679.1M | +35.7% |
| Current Liabilities | $104.6M | — |
| Long-term Debt | $15.4M | +0.0% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$261.3M | -216.4% |
| Capital Expenditures | $26.1M | -30.7% |
| Investing Cash Flow | -$31.0M | -550.4% |
| Financing Cash Flow | $515.2M | +434.0% |
| Free Cash Flow | -$287.4M | -139.0% |
| Total Liabilities |
| $199.7M |
| -47.4% |
| Stockholders' Equity | $479.3M | +9486.8% |